DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Equities researchers at Barrington Research lowered their FY2017 earnings per share (EPS) estimates for DENTSPLY SIRONA in a research report issued on Wednesday. Barrington Research analyst M. Petusky now anticipates that the medical instruments supplier will post earnings per share of $2.65 for the year, down from their prior forecast of $2.67. Barrington Research also issued estimates for DENTSPLY SIRONA’s FY2018 earnings at $2.78 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.65. The firm had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The business’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period last year, the company earned $0.76 EPS.

ILLEGAL ACTIVITY WARNING: “FY2017 Earnings Forecast for DENTSPLY SIRONA Inc. Issued By Barrington Research (XRAY)” was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/10/06/fy2017-earnings-forecast-for-dentsply-sirona-inc-issued-by-barrington-research-xray.html.

Several other brokerages also recently issued reports on XRAY. BidaskClub downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. Credit Suisse Group AG reiterated an “outperform” rating and set a $75.00 price target (up from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target for the company in a report on Thursday, July 13th. HC Wainwright began coverage on shares of DENTSPLY SIRONA in a report on Tuesday, July 11th. They set a “buy” rating and a $74.00 price target for the company. Finally, Cleveland Research downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a report on Thursday. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $65.67.

DENTSPLY SIRONA (NASDAQ XRAY) opened at 58.98 on Friday. DENTSPLY SIRONA has a 12 month low of $52.54 and a 12 month high of $65.68. The company’s market capitalization is $13.54 billion. The firm has a 50-day moving average price of $57.06 and a 200-day moving average price of $61.28.

Institutional investors have recently modified their holdings of the stock. Commonwealth Bank of Australia grew its stake in shares of DENTSPLY SIRONA by 19.0% in the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares during the last quarter. Acrospire Investment Management LLC bought a new stake in shares of DENTSPLY SIRONA in the second quarter worth $113,000. Dupont Capital Management Corp bought a new stake in shares of DENTSPLY SIRONA in the second quarter worth $116,000. Korea Investment CORP grew its stake in shares of DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after purchasing an additional 1,251 shares during the last quarter. Finally, Sphera Funds Management LTD. bought a new stake in shares of DENTSPLY SIRONA in the second quarter worth $162,000. 93.87% of the stock is currently owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.